#United States #Class Action #Texas #Pomerantz #Nutex Health

Class Action Lawsuit Filed Against Nutex Health Inc.

On September 13, 2025, the Pomerantz Law Firm announced that a class action lawsuit has been initiated against Nutex Health Inc., also referred to simply as Nutex, and certain key officers within the company. This action was filed in the United States District Court, specifically for the Southern District of Texas, under the case number 25-cv-03999. The lawsuit primarily caters to individuals and entities (excluding the defendants) who purchased or acquired Nutex securities from August 8, 2024, to August 14, 2025, which is referred to as the Class Period. The goal of the lawsuit is to recoup damages resulting from alleged violations of federal securities laws by Nutex and its personnel.

Investors who believe they fall within the parameters of this class action have until October 21, 2025, to petition the Court for Lead Plaintiff designation. Details regarding the lawsuit can be accessed through the Pomerantz Law Firm’s website. Investors seeking further clarification can reach out to Danielle Peyton via email or telephone as provided in the release.

Background on Nutex Health

Nutex Health, which commenced public trading through a reverse merger in April 2022, functions as a physician-led healthcare services and operations company. It operates across three main divisions: a hospital division managing 24 facilities in 11 states, a population health management division, and a real estate division. Nutex’s revenue primarily comes from out-of-network healthcare services, with over 90% of its net patient service income derived from contracts with third-party payors, including commercial insurance, workers' compensation, and, in limited instances, Medicare or Medicaid.

Previously, under the traditional out-of-network model, patients receiving care from out-of-network providers could face unexpectedly high costs unless laws restricted this practice—a situation commonly referred to as